MX2008014298A - Ácido 2-n-{5-[[4-[2-(metil-2-piridinilamino)etoxi]fenil]metil]-2,4 -tiazolidindiona}butanodioico, metodos de preparacion y composiciones con maleato de rosiglitazona. - Google Patents

Ácido 2-n-{5-[[4-[2-(metil-2-piridinilamino)etoxi]fenil]metil]-2,4 -tiazolidindiona}butanodioico, metodos de preparacion y composiciones con maleato de rosiglitazona.

Info

Publication number
MX2008014298A
MX2008014298A MX2008014298A MX2008014298A MX2008014298A MX 2008014298 A MX2008014298 A MX 2008014298A MX 2008014298 A MX2008014298 A MX 2008014298A MX 2008014298 A MX2008014298 A MX 2008014298A MX 2008014298 A MX2008014298 A MX 2008014298A
Authority
MX
Mexico
Prior art keywords
compound
pharmaceutical composition
formula
rosiglitazone maleate
sealed package
Prior art date
Application number
MX2008014298A
Other languages
English (en)
Spanish (es)
Inventor
Minutza Leibovici
Yehudit Dolitzky
Yoseph Avezov
Dina Spivak
Ben-Zion Salomon
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MX2008014298A publication Critical patent/MX2008014298A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX2008014298A 2006-05-09 2006-05-09 Ácido 2-n-{5-[[4-[2-(metil-2-piridinilamino)etoxi]fenil]metil]-2,4 -tiazolidindiona}butanodioico, metodos de preparacion y composiciones con maleato de rosiglitazona. MX2008014298A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/017994 WO2007130064A1 (fr) 2006-05-09 2006-05-09 Acide 2-n-(5-[[4-(2-methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione)butanedioique, procedes de preparation et compositions a base de maleate de rosiglitazone

Publications (1)

Publication Number Publication Date
MX2008014298A true MX2008014298A (es) 2008-11-26

Family

ID=38668055

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008014298A MX2008014298A (es) 2006-05-09 2006-05-09 Ácido 2-n-{5-[[4-[2-(metil-2-piridinilamino)etoxi]fenil]metil]-2,4 -tiazolidindiona}butanodioico, metodos de preparacion y composiciones con maleato de rosiglitazona.

Country Status (8)

Country Link
JP (1) JP2009536643A (fr)
CN (1) CN101426789A (fr)
BR (1) BRPI0621551A2 (fr)
CA (1) CA2647829A1 (fr)
IL (2) IL188175A0 (fr)
MX (1) MX2008014298A (fr)
NO (2) NO20085124L (fr)
WO (1) WO2007130064A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010013141A2 (fr) * 2008-08-01 2010-02-04 Actavis Group Ptc Ehf Hydrogénosulfate de rosiglitazone essentiellement pur
CN102863436B (zh) * 2012-06-19 2018-02-09 重庆医科大学 噻唑烷二酮类衍生物及其制备和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives

Also Published As

Publication number Publication date
NO20085124L (no) 2009-02-04
CA2647829A1 (fr) 2007-11-15
NO20092362L (no) 2009-02-04
IL199822A0 (en) 2011-07-31
WO2007130064A1 (fr) 2007-11-15
WO2007130064A8 (fr) 2008-11-13
BRPI0621551A2 (pt) 2016-08-16
CN101426789A (zh) 2009-05-06
JP2009536643A (ja) 2009-10-15
IL188175A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
EP2477611B1 (fr) Formulations de comprimés d'acide (z)-2-cyano-3-hydroxy-but-2-énoïque-(4'-trifluorméthylphényl)-amide à stabilité améliorée
US20060247278A1 (en) Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
EP2121716B1 (fr) Compositions de tiacumicines stables
CN106890147A (zh) 含1‑(β‑D‑吡喃葡糖基)‑3‑(苯基噻吩基甲基)苯化合物的片剂
CN101890028A (zh) 稳定化药物组合物
EP1891952B1 (fr) Composition pharmaceutique d'olmésartan médoxomil
US20100081695A1 (en) 2-N-{5-[ [4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20210393626A1 (en) Pharmaceutical Composition Comprising PARP Inhibitors
US20110224249A1 (en) Novel Hydrate Form
EP1854794A1 (fr) Acide 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioique, procédés de préparation et compositions avec le maléate de rosiglitazone
MX2008014298A (es) Ácido 2-n-{5-[[4-[2-(metil-2-piridinilamino)etoxi]fenil]metil]-2,4 -tiazolidindiona}butanodioico, metodos de preparacion y composiciones con maleato de rosiglitazona.
US10583087B2 (en) Pharmaceutical composition for oral administration
US20080113022A1 (en) Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
JP7102200B2 (ja) コハク酸ソリフェナシン含有固形医薬組成物
CN112999181A (zh) 一种富马酸沃诺拉赞片剂
KR20090006841A (ko) ２―ｎ―｛５―［［４―［２―（메틸―２―피리디닐아미노）에톡시］페닐］메틸］―２、４―티아졸리딘다이온｝뷰탄다이오산, 그 제조방법 및 말레산 로지글리타존을 지닌 조성물
JPWO2020111089A1 (ja) 医薬組成物
DE202006020710U1 (de) Zusammensetzungen mit Rosiglitazonmaleat
CA3072347A1 (fr) Formes cristallines de composes pour prevenir ou traiter la mort de cellules ciliees sensorielles
RU2777433C2 (ru) Способ получения безводной аморфной формы n-(2-хлор-6-метилфенил)-2-[[6-[4-(2-гидроксиэтил)-1-пиперазинил]-2-метил-4-пиримидинил]амино]-5-тиазолкарбоксамида
CN113173881B (zh) 羟尼酮的晶型及其制备方法和用途
CN102241644B (zh) α-氨基-3-芳基丙酰胺基噻唑衍生物、其制备方法和用途
KR20210027305A (ko) 둘록세틴이 함유된 안정한 다중코팅 정제 조성물
CN115569119A (zh) 具有改善稳定性的阿拉莫林片剂的生产方法